Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

New Nanomaterial Promises Enhanced Detection and Treatment of Breast Cancer

By BiotechDaily International staff writers
Posted on 07 Jan 2014
Image: Muonium [an exotic atom made up of an antimuon and an electron] trapped inside a buckyball. Muons provide a complementary probe to neutrons, particularly in the areas of magnetism, superconductivity, and charge transport (Photo courtesy of ISIS).
Image: Muonium [an exotic atom made up of an antimuon and an electron] trapped inside a buckyball. Muons provide a complementary probe to neutrons, particularly in the areas of magnetism, superconductivity, and charge transport (Photo courtesy of ISIS).
A collaboration of scientists from the United Kingdom, Denmark, Brazil, and Germany are devising new detection and treatment technology for breast cancer patients.

The study’s findings were published December 2013 in the Journal of Alloys and Compounds. Current diagnostic methods such as mammograms can only detect between 65% and 95% of tumors, and developing better ways of detection is of prime urgency. If not detected and treated early enough, breast cancer can spread to other areas of the body, increasing the probability that the disease will become lethal.

The team of scientists has been using the Polaris instrument at the ISIS pulsed neutron and muon source at the Rutherford Appleton Laboratory (Harwell Oxford, UK) to develop a new bio-nanocomposite that they hope will eventually lead to earlier detection, and more successful treatment, of breast cancer. The new substance exploits the fact that cancer cells attract a molecule called hydroxyapatite, which is a component of bones. The researchers are developing magnetic nanoparticles coated with a biocompatible polymer that includes hydroxyapatite nanocrystals. When administered into the body, these nanoparticles should travel right to cancer cells, and once they do, they make it much easier to detect the tumor on an MRI scan.

Not only do the nanoparticles help to identify tumors, but they may also help to block the metastasis to other areas of the body, as hydroxyapatite is known to suppress that facet of tumor activity.

The next phase of study is to incorporate antitumor agents into the nanoparticles. The magnetic nature of the nanoparticles means that they can be directed to the site of the tumor by using magnets outside of the body. If antitumor drugs can be added to the nanoparticles, then they can be used to deliver the treatment directly to the tumor, optimizing the effectiveness of the treatment and reducing the risk of harmful side effects--imagine a fleet of tiny drones, delivering anticancer weapons right where they are needed.

This research is at a very early stage, and far more study is required, according to the scientists, before it can be developed into a treatment option.

ISIS generates beams of neutrons and muons that allow scientists to study materials at the atomic level using a suite of instruments, frequently described as super-microscopes. It supports a national and international community of more than 2,000 scientists who use neutrons and muons for research in physics, chemistry, materials science, geology, engineering, and biology.

Related Links:

ISIS



Channels

Genomics/Proteomics

view channel
Image: Biopsy of small bowel showing celiac disease manifested by blunting of villi, crypt hyperplasia, and lymphocyte infiltration of crypts (Photo courtesy of Wikimedia Commons).

Reduced Elafin Levels Associated with Celiac Disease Bowel Inflammation

Levels of the enzyme elafin, an endogenous serine protease inhibitor, were lower in the small intestinal epithelium of patients with active celiac disease (CD) as compared to similar tissue from control patients.... Read more

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.